Table II.
Features | Case | Lewis(y)
|
MUC1
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Positive cases | Rate (%) | P-value | MOD | P-value | Positive cases | Rate (%) | P-value | MOD | P-value | ||
FIGO stage | |||||||||||
I–II | 39 | 33 | 84.62 | >0.05 | 0.438±0.089 | <0.05 | 31 | 79.49 | >0.05 | 0.421±0.097 | <0.05 |
III–IV | 21 | 20 | 95.24 | 0.501±0.098 | 21 | 100 | 0.510±0.083 | ||||
Differentiation level | |||||||||||
High | 21 | 17 | 80.95 | >0.05 | 0.431±0.089 | <0.05a | 18 | 85.71 | >0.05 | 0.440±0.095 | <0.05a |
Moderate | 21 | 18 | 85.71 | 0.465±0.092 | >0.05b | 17 | 80.95 | 0.456±0.081 | >0.05b | ||
Poor | 18 | 18 | 100 | 0.493±0.104 | <0.05c | 17 | 94.44 | 0.476±0.092 | <0.05c | ||
Lymphatic metastasis | |||||||||||
No | 48 | 41 | 85.42 | >0.05 | 0.457±0.094 | >0.05 | 42 | 87.5 | >0.05 | 0.451±0.098 | >0.05 |
Yes | 12 | 12 | 100 | 0.489±0.077 | 10 | 83.33 | 0.485±0.069 |
Compared with the low differentiation group;
compared with the low and high differentiation groups;
compared with the high differentiation group.